Lexicon Pharmaceuticals Inc
Biotechnology
Healthcare
LXRX
362 M shares
NASDAQ US
traded
17 Jul 2025
listed
no
open
1.30
52 week high
1.35
high
1.43
52 week low
0.00
low
1.29
growth
0.00 %
previous Close
P/E ratio
market cap
490 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
2004.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top